Amanote Research
Register
Sign In
Randomized Trial Evaluating Ranibizumab Plus Prompt or Deferred Laser or Triamcinolone Plus Prompt Laser for Diabetic Macular Edema
Acta Ophthalmologica
- United States
doi 10.1111/j.1755-3768.2010.4111.x
Full Text
Open PDF
Abstract
Available in
full text
Categories
Medicine
Ophthalmology
Date
September 1, 2010
Authors
P EDWARDS
Publisher
Wiley
Related search
Expanded 2-Year Follow-Up of Ranibizumab Plus Prompt or Deferred Laser or Triamcinolone Plus Prompt Laser for Diabetic Macular Edema
Ophthalmology
Ophthalmology
Five-Year Outcomes of Ranibizumab With Prompt or Deferred Laser Versus Laser or Triamcinolone Plus Deferred Ranibizumab for Diabetic Macular Edema
American Journal of Ophthalmology
Ophthalmology
Intravitreal Ranibizumab for Diabetic Macular Edema With Prompt Versus Deferred Laser Treatment
Ophthalmology
Ophthalmology
Intravitreal Ranibizumab for Diabetic Macular Edema With Prompt Versus Deferred Laser Treatment: 5-Year Randomized Trial Results
Ophthalmology
Ophthalmology
Macular Laser Grid Alone Versus Combined With Intravitreal Triamcinolone Plus Bevacizumab for Diabetic Macular Edema
Journal of Pharmaceutical and Scientific Innovation
Aflibercept, Bevacizumab, or Ranibizumab for Diabetic Macular Edema
Ophthalmology
Ophthalmology
Green or Yellow Laser Treatment for Diabetic Macular Edema
Retina
Medicine
Ophthalmology
Comparison of Natural Course, Intravitreal Triamcinolone and Macular Laser Photocoagulation for Treatment of Mild Diabetic Macular Edema
International Journal of Medical Sciences
Medicine
Re: Wells Et Al.: Aflibercept, Bevacizumab, or Ranibizumab for Diabetic Macular Edema: Two-Year Results From a Comparative Effectiveness Randomized Clinical Trial (Ophthalmology 2016;123:1351-1359)
Ophthalmology
Ophthalmology
